Marco Pappagallo
Corporate Officer/Principal bij Sapienza University of Rome
Profiel
Marco Pappagallo is the founder of Novapharm Therapeutics, which was founded in 2010.
He held the title of Chief Medical Officer at Novapharm Therapeutics.
Currently, Dr. Pappagallo is a Professor at Sapienza University of Rome.
In the past, he worked as the Director-Chronic Pain at Beth Israel Medical Center, The Johns Hopkins University, and Icahn School of Medicine at Mount Sinai.
He also served as the Director-Pain Research & Professor-Anesthesiology at The Mount Sinai Medical Center, Inc. Additionally, Dr. Pappagallo worked as the Executive Director-Medical Intelligence at Grünenthal USA, Inc. and as a Professor at Albert Einstein College of Medicine, Inc. He was also the Chief Medical Officer at Cersci Therapeutics, Inc. Currently, Dr. Pappagallo is the Chief Clinical Officer at Relmada Therapeutics, Inc. from 2020 to 2023.
Dr. Pappagallo obtained a doctorate degree from The American University of Rome.
Actieve functies van Marco Pappagallo
| Bedrijven | Functie | Begin |
|---|---|---|
| Sapienza University of Rome | Corporate Officer/Principal | - |
Eerdere bekende functies van Marco Pappagallo
| Bedrijven | Functie | Einde |
|---|---|---|
| RELMADA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2023 |
| Albert Einstein College of Medicine, Inc. | Corporate Officer/Principal | 01-01-2014 |
The Mount Sinai Medical Center, Inc.
 The Mount Sinai Medical Center, Inc. Hospital/Nursing ManagementHealth Services The Mount Sinai Medical Center, Inc. operates charitable teaching hospitals. The non-profit company is based in New York, NY. The CEO of the company is Gino Santorio. | Corporate Officer/Principal | - |
| The Johns Hopkins University | Corporate Officer/Principal | - |
| Icahn School of Medicine at Mount Sinai | Corporate Officer/Principal | - |
Opleiding van Marco Pappagallo
| The American University of Rome | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| RELMADA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
Beth Israel Medical Center
 Beth Israel Medical Center Hospital/Nursing ManagementHealth Services Beth Israel Medical Center provided health care services. The firm operates outpatient care center. The company was headquartered in New York, NY. | Health Services |
The Mount Sinai Medical Center, Inc.
The Mount Sinai Medical Center, Inc. Hospital/Nursing ManagementHealth Services The Mount Sinai Medical Center, Inc. operates charitable teaching hospitals. The non-profit company is based in New York, NY. The CEO of the company is Gino Santorio. | Health Services |
Grünenthal USA, Inc.
 Grünenthal USA, Inc. Pharmaceuticals: MajorHealth Technology Grünenthal USA, Inc. is a pharmaceutical company based in Morristown, NJ. The private company manufactures and distributes pharmaceutical products. | Health Technology |
Cersci Therapeutics, Inc.
 Cersci Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cersci Therapeutics, Inc. operates as pharmaceutical company. The firm develops non-opioid analgesic drug products without the deleterious side effects. The company was founded by Lucas Rodriguez and Brent Duncan in 2019 and is headquartered in Dallas, TX. | Health Technology |
| Novapharm Therapeutics |
